BridgeBio Oncology Therapeutics, Inc.
Biotechnology
Healthcare
BBOT
69.99 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
11.95
52 week high
12.09
high
11.97
52 week low
0.00
low
11.10
growth
5.63 %
previous Close
12.09
P/E ratio
market cap
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
288.89 %
eps surprise
0.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top